Dr. Neil Edward Schwartz, MD

Dr. Schwartz practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Schwartz's NPI, 1568515039, was assigned on January 19, 2007. Dr. Schwartz graduated from Northwestern University Feinberg Medical School in 2000. Dr. Schwartz holds California license A76229.

Dr. Schwartz's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Schwartz's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Schwartz is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Schwartz to 1 more hospital and 1 medical group, each named with a free account. Dr. Schwartz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Schwartz is licensed in California.

CMS data shows 383 Medicare services from Dr. Schwartz across 8 procedure codes in 2024, for 263 Medicare patients. Medicare paid $46,605 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 62, with 50% women.

In 2024, Dr. Schwartz wrote 85 Medicare Part D claims for 28 patients. 96% of them were for generic drugs. CMS names the drug for 62 of them, across 4 drugs with 11 or more claims each, at $1,274 in total drug cost. In 2023, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 18 papers to Dr. Schwartz, published from 2011 to 2023. 2023 was the busiest year, with 5. The most frequent topics are Embolism, Persistent Left Superior Vena Cava and Pulmonary Veins. Dr. Schwartz has published most often in Circ Cardiovasc Imaging. Dr. Schwartz's most frequent co-authors are Maarten G. Lansberg, MD, Jean-Marc Olivot, MD, PhD and Gregory W. Albers, MD.

Dmand AI links Dr. Schwartz to 3 clinical trials. Conditions studied include Stroke, Cerebrovascular Disorders and Cerebral Hemorrhage. Stanford University sponsors the most, 3.

CMS Open Payments shows 8 general payments to Dr. Schwartz from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $244. It also lists 17 research payments totaling $15,652 from 2017 to 2024.

Dr. Schwartz graduated from Northwestern University Feinberg Medical School in 2000.